BDBM362659 N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridin-2-yl-4,5-dihydroimidazo[1,5,4- de][1,4]benzoxazin-2-yl]piperidin-4- yl}ethanesulfonamide::US10227359, Example 14::US9834565, Example 14
SMILES: CCS(=O)(=O)NC1CCN(CC1)c1nc2ccc(-c3c(C)noc3C)c3OCC(c4ccccn4)n1c23
InChI Key: InChIKey=SJGWGZCUULTQIO-UHFFFAOYSA-N
Data: 4 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BRD4 BD1 (aa 42-168) (Homo sapiens (Human)) | BDBM362659 (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | J Med Chem 51: 1904-12 (2008) BindingDB Entry DOI: 10.7270/Q2D50Q7W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM362659 (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | J Med Chem 51: 1904-12 (2008) BindingDB Entry DOI: 10.7270/Q2D50Q7W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM362659 (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US9834565 (2017) BindingDB Entry DOI: 10.7270/Q29P33XS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
BRD4 BD1 (aa 42-168) (Homo sapiens (Human)) | BDBM362659 (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US9834565 (2017) BindingDB Entry DOI: 10.7270/Q29P33XS | |||||||||||
More data for this Ligand-Target Pair |